使用蒽环类药物阿霉素是限制其心脏毒性。
The use of the anthracycline doxorubicin is restricted by its cardiac toxicity.
阿霉素是一种蒽环类抗生素，具有广谱的抗肿瘤活性。
Doxorubicin (DXR), a well known anti-cancer drug, is a member of the anthracycline ring antibiotics with abroad spectrum of anti-tumor activity.
目前乳腺癌辅助化疗应用最多的仍是蒽环类及紫杉类药物。
Nowaday, the chemotherapeutic drugs of anthracycline and taxane are used widely in breast cancer.
目的：观察参芪扶正液抗蒽环类药物化疗所致心脏毒性的作用。
Objective To observe the heart protection effect of parenteral solution Shenqifuzheng in the chemotherapy with marcellomycin.
本研究旨在观察右丙亚胺治疗蒽环类药物外渗的有效性和安全性。
The purpose of this study was to assess the efficacy and safety of the treatment of anthracycline extravasation with dexrazoxane.
目的：探讨参麦注射液治疗蒽环类药物所致心脏毒性的疗效与不良反应。
Objective: to investigate the therapeutic effect and toxicity of Shenmai injection treatment for patients with cardiotoxicity of anthracycline.
目的探讨减轻蒽环类化疗药物在治疗过程中所致局部不良反应的护理方法。
Objective To probe the nursing method, abate the local side reaction of chemotherapy with doxorubicin.
目的观察吉西他滨联合卡培他滨治疗蒽环类耐药性晚期乳腺癌的疗效与毒性反应。
Objective To observe the results of gemcitabine combined with capecitabine on anthracycline-resistant breast cancer.
方法对近年来10例乳腺癌术后蒽环类药物化疗渗漏损伤的病例进行回顾性总结。
Method Retrospective analysis of 10 cases of breast cancer patients with drug-effusion induced by postoperative anthracene-based chemotherapy.
对复发性乳腺癌患者，吉西他滨的疗效则明显优于蒽环类和紫杉类药物（P<0。01）。
Results In primary breast cancer, the antitumor effect of taxane is better than anthracycline and gemcitabine(P <0.01).
一项新的诊断试验可以将已接受紫杉烷与蒽环类抗生素化疗的高生存率的患者成功分辨出来。
May 13, 2011 - a new test might identify breast cancer patients who have a high probability of survival after taxane and anthracycline chemotherapy.
当研究人员在癌细胞中的两个基因的功能，在实验室中培养，细胞变得非常脆弱的蒽环类化合物。
When the researchers knocked out the two genes' function in cancer cells grown in the laboratory, the cells became vulnerable to anthracycline compounds.
目的：研究1,6 -二磷酸果糖(FDP)对使用蒽环类化疗药致心肌损害的白血病患儿的疗效。
Objective: to investigate the effect of fructose-1, 6-diphosphate (FDP) on myocardial injure induced by anthracycline in children with acute leukemia.
入组的所有305名女性(中位年龄55岁)当中要么已是乳癌晚期患者，要么是乳癌转移患者，而且都接受了蒽环类药物的治疗。
All 305 women in the study (median age 55 years) had locally advanced or metastatic breast cancer, and all had been treated with an anthracycline.
对应用于生物工程的萘、芴、芘、蒽、苊等稠环芳烃衍生物作了概括介绍。
The derivates of naphthalene, fluorene, pyrene, anthracene, acenaphthene and their application in biotechnology were reviewed.
对两种不同的氯丙烯环氧化与蒽醌法生产过氧化氢过程的集成方法进行了研究。
Two different integrated processes of the epoxidation of allyl chloride and production of hydrogen peroxide by anthraquinone route were investigated.
采用静态实验方法研究了多环芳烃荧蒽对两种海洋硅藻的毒性作用。
The toxic effects of fluoranthene on two marine diatoms were investigated using the static method.
将蒽醌环上引入不同的基团则成为不同的染料。
When the anthraquinone ring is led into different group, it changes into a differentd yestuff.
加入少量的萘、蒽等稠环芳烃于庚烷溶剂中，则大大提高高聚物的分子量。
Addition of small amount of polynuclear hydrocarbons, such as naphthalene or anthracene to the heptane polymerization solution raised the molecular weight of the polymer to a considerable extent.
以叔戊苯和笨酐为原料，通过酰基化和关环合成了2—戊基蒽醌，改进和优化了各步合成工艺条件，酰化收率80.2％，关环产品收率81.4％。
An improved and optimum process for preparing 2-Amylanthraquinone by re-acting t-amylbenzene with phthalic anhydride, involving Friedel-Crafts acylation (yield 80. 2%) and cyclization(yield 81.4%).
以叔戊苯和笨酐为原料，通过酰基化和关环合成了2—戊基蒽醌，改进和优化了各步合成工艺条件，酰化收率80.2％，关环产品收率81.4％。
An improved and optimum process for preparing 2-Amylanthraquinone by re-acting t-amylbenzene with phthalic anhydride, involving Friedel-Crafts acylation (yield 80. 2%) and cyclization(yield 81.4%).
应用推荐